Tag: Lazertinib
-

Yuhan Corporation Accelerates Global Leap with Lazertinib’s European Commercialization
A domestic pharmaceutical company with a long history and tradition is making its presence felt on the global stage, recently delivering a series of significant news. In particular, the European commercialization of ‘Lazertinib’, a treatment, marks a crucial turning point in ‘s strategy to penetrate overseas markets. The achievement of not just technology export but…